59 related articles for article (PubMed ID: 94871)
1. [Prevention of reinfarction with acetylsalicylic acid].
Vogel G; Fischer C; Huyke R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):797-803. PubMed ID: 94871
[TBL] [Abstract][Full Text] [Related]
2. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
3. [Course control of platelet function and blood lipid levels during a 2 years prospective study on the prevention of reinfarction with acetylsalicylic acid, phenprocoumon and placebo].
Walter E; Weber E; Loew D
Verh Dtsch Ges Inn Med; 1978; (84):1481-5. PubMed ID: 369187
[No Abstract] [Full Text] [Related]
4. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
Breddin K; Loew D; Lechner K; Uberla K; Walter E
Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
[No Abstract] [Full Text] [Related]
5. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
Breddin HK; Uberla KK
Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
[No Abstract] [Full Text] [Related]
6. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
7. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
Weber E; Walter E; Pfleiderer T
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
[No Abstract] [Full Text] [Related]
8. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.
Cruz-Fernández JM; López-Bescós L; García-Dorado D; López García-Aranda V; Cabadés A; Martín-Jadraque L; Velasco JA; Castro-Beiras A; Torres F; Marfil F; Navarro E
Eur Heart J; 2000 Mar; 21(6):457-65. PubMed ID: 10681486
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
[TBL] [Abstract][Full Text] [Related]
10. The anturane reinfarction trial.
Sherry S
Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
[TBL] [Abstract][Full Text] [Related]
11. [Platelet aggregation inhibitor in general practice. Every 3rd infarct prevented--reinfarction rate cut in half].
Fliri M
MMW Fortschr Med; 2002 Aug; 144(33-34):38-41. PubMed ID: 12380142
[TBL] [Abstract][Full Text] [Related]
12. Superior prevention of reinfarction by 30 mg/d aspirin compared with 1000 mg/d: results of a two years follow-up study in Cottbus.
Förster W; Hoffmann W
Biomed Biochim Acta; 1988; 47(10-11):S248-51. PubMed ID: 3073765
[TBL] [Abstract][Full Text] [Related]
13. [Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
Fortschr Med; 1980 Aug; 98(32):1227-8. PubMed ID: 7409723
[No Abstract] [Full Text] [Related]
14. Two years follow-up Cottbus reinfarction study with 30 and 60 mg acetylsalicylic acid.
Hoffmann W; Förster W
Prog Clin Biol Res; 1987; 242():393-7. PubMed ID: 3671392
[No Abstract] [Full Text] [Related]
15. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of myocardial infarct. Evaluation of a 2-year trial comparing acetylsalicylic acid to oral anticoagulants].
Rev Prat; 1978 Jan; 28(1):43-56. PubMed ID: 635389
[No Abstract] [Full Text] [Related]
17. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of transitory ischemic attacks with acetylsalicylic acid: results of a double-blind-study (author's transl)].
Reuther R; Dorndorf W; Loew D
MMW Munch Med Wochenschr; 1980 May; 122(21):795-8. PubMed ID: 6771599
[TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of recurrences of myocardial infarction. Results in 2026 patients monitored for 44 months in a group study].
Sem Hop; 1980 Oct 18-25; 56(39-40):1575-7. PubMed ID: 6255571
[No Abstract] [Full Text] [Related]
20. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).
Gibson CM; Ly HQ; Murphy SA; Ciaglo LN; Southard MC; Stein EB; Buros JL; Sabatine MS; Cannon CP;
Am J Cardiol; 2006 Sep; 98(6):761-3. PubMed ID: 16950180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
